Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. Summary
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
Delayed Quote. Delayed Swiss Exchange - 09/17 11:31:37 am
77.44 CHF   -0.58%
09/17NOVARTIS AG : Deutsche Bank sticks Neutral
MD
09/17NOVARTIS : Releases Results For Efficacy Of Alpelisib Drug
MT
09/17PRESS RELEASE : Novartis announces findings from a -2-
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVARTIS AG
09/17NOVARTIS AG : Deutsche Bank sticks Neutral
MD
09/17NOVARTIS : Releases Results For Efficacy Of Alpelisib Drug
MT
09/17PRESS RELEASE : Novartis announces findings from a -2-
DJ
09/17PRESS RELEASE : Novartis announces findings from a real-world study of alpelisib..
DJ
09/17Novartis announces findings from a real-world study of alpelisib demonstratin..
DJ
09/17NOVARTIS : Study Shows Potential of Radioligand Therapy in Prostate Cancer
MT
09/17NOVARTIS : Therapy Delays Difficult-To-Bear Symptoms in Late-Stage Prostate Canc..
MT
09/16Novartis Prostate-Cancer Treatment Gets Positive Quality of Life Data
DJ
09/16Novartis reports positive health-related quality of life data for 177Lu-PSMA-..
DJ
09/16PRESS RELEASE : Novartis reports positive health-related quality of life data fo..
DJ
09/16PRESS RELEASE : Novartis reports positive -2-
DJ
09/14NOVARTIS AG : JP Morgan reiterates its Sell rating
MD
09/13NOVARTIS AG : Gets a Neutral rating from Deutsche Bank
MD
09/13NOVARTIS : Wins Swissmedic Nod for Cholesterol Drug Leqvio
MT
09/13NOVARTIS : Morningstar Lowers Price Target on Novartis, Maintains Hold Recommend..
MT
More most relevant news
All news about NOVARTIS AG
09/17NOVARTIS AG : Deutsche Bank sticks Neutral
MD
09/17NOVARTIS : Releases Results For Efficacy Of Alpelisib Drug
MT
09/17PRESS RELEASE : Novartis announces findings from a -2-
DJ
09/17PRESS RELEASE : Novartis announces findings from a real-world study of alpelisib..
DJ
09/17Novartis announces findings from a real-world study of alpelisib demonstratin..
DJ
09/17NOVARTIS : Study Shows Potential of Radioligand Therapy in Prostate Cancer
MT
09/17NOVARTIS : Therapy Delays Difficult-To-Bear Symptoms in Late-Stage Prostate Canc..
MT
09/16Novartis Prostate-Cancer Treatment Gets Positive Quality of Life Data
DJ
09/16Novartis reports positive health-related quality of life data for 177Lu-PSMA-..
DJ
09/16PRESS RELEASE : Novartis reports positive health-related quality of life data fo..
DJ
More news
News in other languages on NOVARTIS AG
09/17Aktien Schweiz: SMI schliesst am Hexensabbat deutlich tiefer
09/17Bourse Zurich: le SMI chute et finit sous la barre des 12'000 points
09/17WOCHENVORSCHAU : Termine bis 1. Oktober 2021
09/17Novartis vise une nouvelle indication pour alpelisib
09/17DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 17.09.2021 - 15.15 Uhr
09/17NOVARTIS : nouvelles donnés dans le syndrome de surcroissance
09/17Novartis publie les résultats de l'efficacité du médicament Alpelisib
09/17Novartis erzielt erste Erfolge mit Alpelisib in Behandlung von Grosswuchssynd..
09/17Aktien Schweiz: Freundlich zu Wochenschluss
09/17Bourse Zurich: l'enthousiasme s'essouffle en fin de matinée
More news
Analyst Recommendations on NOVARTIS AG
09/17NOVARTIS AG : Deutsche Bank sticks Neutral
MD
09/14NOVARTIS AG : JP Morgan reiterates its Sell rating
MD
09/13NOVARTIS AG : Gets a Neutral rating from Deutsche Bank
MD
09/13NOVARTIS : Morningstar Lowers Price Target on Novartis, Maintains Hold Recommend..
MT
09/06NOVARTIS AG : Kepler Cheuvreux reaffirms its Neutral rating
MD
More recommendations
Press releases
09/13NOVARTIS : announces first FDA filing acceptance for anti-PD-1 antibody tisleliz..
PU
09/08NOVARTIS : Sandoz strengthens pipeline by entering into agreement for biosimilar..
AQ
09/03NOVARTIS : presents new findings at ERS reinforcing the efficacy of Enerzair® Br..
PU
09/02NOVARTIS : PTEs (patent term extensions) in Australia – More hard lessons ..
AQ
09/01ACURX PHARMACEUTICAL'S IS DISRUPTIVE : Acxp)
AQ
More press releases
Upcoming event on NOVARTIS AG